FCM
AGN

Frontier Capital Management’s Allergan plc AGN Stock Holding History

Frontier Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3,737
Closed -$861K – 355
2016
Q3 		$861K Sell
3,737
-555
-13% -$136K 0.01% 296
2016
Q2 		$992K Sell
4,292
-415
-9% -$95.7K 0.01% 292
2016
Q1 		$1.26M Sell
4,707
-623
-12% -$178K 0.01% 295
2015
Q4 		$1.67M Sell
5,330
-2,425
-31% -$722K 0.01% 302
2015
Q3 		$2.11M Sell
7,755
-5,018
-39% -$1.54M 0.02% 303
2015
Q2 		$3.88M Sell
12,773
-863
-6% -$257K 0.03% 295
2015
Q1 		$4.06M Sell
13,636
-14,378
-51% -$4.1M 0.03% 296
2014
Q4 		$7.21M Sell
28,014
-3,442
-11% -$860K 0.05% 280
2014
Q3 		$7.59M Sell
31,456
-464,952
-94% -$104M 0.06% 268
2014
Q2 		$111M Sell
496,408
-170,524
-26% -$35.3M 0.81% 24
2014
Q1 		$137M Sell
666,932
-531,160
-44% -$105M 0.99% 13
2013
Q4 		$201M Buy
1,198,092
+83,631
+8% +$13.1M 1.49% 3
2013
Q3 		$160M Buy
1,114,461
+13
+0% +$1.73K 1.24% 9
2013
Q2 		$141M Buy
+1,114,448
New +$126M 1.17% 8

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Frontier Capital Management's AGN Position: Q4 2016 in Review

Frontier Capital Management sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 3,737 shares — an estimated $861K sold.

Frontier Capital Management first reported a position in AGN in Q2 2013 and held it in 14 quarters. The position peaked at $201M in Q4 2013. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Frontier Capital Management reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Frontier Capital Management sold 3,737 Allergan plc shares in Q4 2016, an estimated $861K.
  • Frontier Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 14 quarters.
  • Frontier Capital Management's Allergan plc position peaked at $201M in Q4 2013.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Frontier Capital Management's 13F filing for Q4 2016, filed 3 Feb 2017.